Xcout Intel
Metabolomic Diagnostics
Metabolomic Diagnostics is a biotechnology company located in Little Island, County Cork, Ireland, focused on metabolomics research and diagnostic solutions.
Subscribe to see Metabolomic Diagnostics’s full profile → the full roster, investors in every round, weekly hiring history and every corporate event
Metabolomic Diagnostics at a glance
Metabolomic Diagnostics is a biotech company headquartered in Ireland. It has raised at least $1.8M across the 2 funding rounds on record. Its most recent funding round, Seed, raised $1M in February 2015. Xcout tracks 1 named person at Metabolomic Diagnostics, including Dr. Robin Tuytten (Director).
Metabolomic Diagnostics leadership
- Dr. Robin TuyttenDirector
Metabolomic Diagnostics funding rounds
At least $1.8M raised across the 2 rounds on record. Every round on record:
| Date | Round | Amount | Investors |
|---|---|---|---|
| Seed | $1M | — | |
| Seed | $750,000 | — |
Who invested in each round, lead investors, valuations and the co-investor graph — open the full funding history →
Metabolomic Diagnostics competitors
A few of Metabolomic Diagnostics's closest competitors — see the full list of competitors and alternatives →
Human Metabolome Technologies, Inc. is a biotechnology company based in Tsuruoka, Japan, established in 2003. It focuses on developing and providing metabolomics technologies and solutions for a range of applications, including drug discovery, disease diagnosis, and food production primarily within Japan. The company offers a comprehensive suite of metabolome analysis services, encompassing global profiling, targeted assays, flux analysis, and lipidomics. Additionally, it develops biomarkers, such as Phosphorylethanolamine, which is measured in blood plasma as a marker for major depressive disorder. HMT's solutions address diverse areas like cancer metabolism, infectious diseases, basic and clinical research, food and nutrition, and microbiome studies. The company also fosters collaborations, notably with the Institute for Advanced Biosciences and Keio University, to further advance metabolome analysis technology.
IdentiGEN Ltd. is an Ireland-based company providing DNA-based analysis and diagnostics with operations in Ireland, the UK, North America and Canada. Services include species identification, parentage testing, and a food traceability system.
ALACRiS Theranostics GmbH is a pioneering biotechnology research company based in Berlin, Germany, specializing in omics technologies and personalized medicine solutions for health.
ImmunArray is a privately funded molecular diagnostics company co-located in Rehovot, Israel, and Richmond, Virginia. Founded in 2005, the company is dedicated to the development of novel blood-based tests and diagnostic solutions.
Mercy BioAnalytics, Inc. is a privately held biotechnology company founded in 2018 and headquartered in Waltham, Massachusetts. The company is dedicated to developing early diagnostics and detection technologies.
Get Metabolomic Diagnostics's news by email
Funding rounds, acquisitions, new executives, launches and expansions, each with a two-line summary and a link to the source. One short email a day, only when there is news.
Free: up to 5 companies, daily. Subscribers also follow whole sectors and saved filters (M&A in Israel, AI funding…), get instant alerts, in-app notifications and signed webhooks, and open the full profile behind every name. Subscribe →
Share this card
Post the link and the card appears automatically — each network fetches the image itself.
More on Metabolomic Diagnostics in Xcout Intel
- 1 named person with titles, LinkedIn and board committees
- 2 funding rounds with the investors in each, and who they co-invest with
- The full competitor set, tracking, exports and API access